Literature DB >> 34089538

Influence of reduced diffusing capacity and FEV1 on outcome after cardiac surgery.

Emilie C Risom1, Katrine B Buggeskov1, René H Petersen2, Jann Mortensen3, Hanne B Ravn1.   

Abstract

OBJECTIVES: Impaired lung function is a well-known risk factor in cardiac surgery patients and reduced forced expiratory volume in 1 second (FEV1 ) is associated with increased mortality. However, there is limited knowledge regarding the influence of impaired diffusing capacity of the lungs for carbon monoxide (DLCO) in unselected cardiac surgery patients. The aim of this study was to investigate the association of impaired DLCO and/or reduced FEV1 on postoperative mortality and morbidity in cardiac surgery patients.
METHODS: In a prospective cohort study, 390 patients scheduled for elective cardiac surgery underwent a preoperative lung function test including spirometry and DLCO measurements. We defined reduced FEV1 as FEV1 below lower limit of normal (LLN) and impaired DLCO as DLCO<60% of predicted.
RESULTS: Mortality within one year (90-570 days) was significantly higher in patients with impaired DLCO (12% vs 3%, P=0.010) and with reduced FEV1 (9% vs 3%, P=0.028). Mortality was higher in patients with impaired DLCO both in the presence and absence of FEV1 <LLN. In multivariate analysis only impaired DLCO (OR: 3.3, 95% confidence interval (CI) 1.4-7.5; P=0.005) and age (OR: 1.1 per year, 95% CI 1.0-1.2; P=0.001) were independent predictors of the combined outcome of mortality and prolonged intensive care unit (ICU) stay. Impaired DLCO was also associated with postoperative respiratory complications.
CONCLUSION: In patients undergoing elective cardiac surgery, preoperative impaired FEV1 and DLCO were associated with increased mortality and morbidity. In multivariate analysis only DLCO and age were independent predictors of a combined outcome of mortality and prolonged ICU stay. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  AVR; CABG; Cardiac surgery; DLCO; FEV1; Lung function; Mortality; Postoperative mortality; Pulmonary function

Year:  2021        PMID: 34089538     DOI: 10.1111/aas.13935

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  1 in total

1.  Predictive model of postoperative pneumonia after neoadjuvant immunochemotherapy for esophageal cancer.

Authors:  Wei Wang; Yongkui Yu; Haibo Sun; Zongfei Wang; Yan Zheng; Guanghui Liang; Peinan Chen; Jiwei Cheng; Xiaoxia Xu; Funa Yang; Qi Liu; Weiqun Xing
Journal:  J Gastrointest Oncol       Date:  2022-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.